These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 26775841)
1. Targeting colorectal cancer cells by a novel sphingosine kinase 1 inhibitor PF-543. Ju T; Gao D; Fang ZY Biochem Biophys Res Commun; 2016 Feb; 470(3):728-734. PubMed ID: 26775841 [TBL] [Abstract][Full Text] [Related]
2. Icaritin activates JNK-dependent mPTP necrosis pathway in colorectal cancer cells. Zhou C; Chen Z; Lu X; Wu H; Yang Q; Xu D Tumour Biol; 2016 Mar; 37(3):3135-44. PubMed ID: 26427664 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-101 down-regulates sphingosine kinase 1 in colorectal cancer cells. Chen MB; Yang L; Lu PH; Fu XL; Zhang Y; Zhu YQ; Tian Y Biochem Biophys Res Commun; 2015 Aug; 463(4):954-60. PubMed ID: 26071354 [TBL] [Abstract][Full Text] [Related]
4. AT7867 Inhibits Human Colorectal Cancer Cells via AKT-Dependent and AKT-Independent Mechanisms. Zhang S; Deng Z; Yao C; Huang P; Zhang Y; Cao S; Li X PLoS One; 2017; 12(1):e0169585. PubMed ID: 28081222 [TBL] [Abstract][Full Text] [Related]
5. Targeting sphingosine kinase 2 (SphK2) by ABC294640 inhibits colorectal cancer cell growth in vitro and in vivo. Xun C; Chen MB; Qi L; Tie-Ning Z; Peng X; Ning L; Zhi-Xiao C; Li-Wei W J Exp Clin Cancer Res; 2015 Sep; 34(1):94. PubMed ID: 26337959 [TBL] [Abstract][Full Text] [Related]
6. Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1. Schnute ME; McReynolds MD; Kasten T; Yates M; Jerome G; Rains JW; Hall T; Chrencik J; Kraus M; Cronin CN; Saabye M; Highkin MK; Broadus R; Ogawa S; Cukyne K; Zawadzke LE; Peterkin V; Iyanar K; Scholten JA; Wendling J; Fujiwara H; Nemirovskiy O; Wittwer AJ; Nagiec MM Biochem J; 2012 May; 444(1):79-88. PubMed ID: 22397330 [TBL] [Abstract][Full Text] [Related]
7. Aqueous Oldenlandia diffusa extracts inhibits colorectal cancer cells via activating AMP-activated protein kinase signalings. Lu PH; Chen MB; Ji C; Li WT; Wei MX; Wu MH Oncotarget; 2016 Jul; 7(29):45889-45900. PubMed ID: 27322552 [TBL] [Abstract][Full Text] [Related]
8. The preclinical analysis of TW-37 as a potential anti-colorectal cancer cell agent. Lei S; Ding Y; Fu Y; Wu S; Xie X; Wang C; Liang H PLoS One; 2017; 12(10):e0184501. PubMed ID: 29065135 [TBL] [Abstract][Full Text] [Related]
9. NPC-26 kills human colorectal cancer cells via activating AMPK signaling. Zhao Z; Feng L; Wang J; Cheng D; Liu M; Ling M; Xu W; Sun K Oncotarget; 2017 Mar; 8(11):18312-18321. PubMed ID: 28407688 [TBL] [Abstract][Full Text] [Related]
10. Pre-clinical characterization of PKC412, a multi-kinase inhibitor, against colorectal cancer cells. Li JP; Huang ZJ; Lu XS; Zhou YC; Shao Y; He XP; Chen SR; Wang DD; Qin LS; Sun WH Oncotarget; 2016 Nov; 7(47):77815-77824. PubMed ID: 27780925 [TBL] [Abstract][Full Text] [Related]
11. Erastin Disrupts Mitochondrial Permeability Transition Pore (mPTP) and Induces Apoptotic Death of Colorectal Cancer Cells. Huo H; Zhou Z; Qin J; Liu W; Wang B; Gu Y PLoS One; 2016; 11(5):e0154605. PubMed ID: 27171435 [TBL] [Abstract][Full Text] [Related]
12. Mitochondrial protein cyclophilin-D-mediated programmed necrosis attributes to berberine-induced cytotoxicity in cultured prostate cancer cells. Zhang LY; Wu YL; Gao XH; Guo F Biochem Biophys Res Commun; 2014 Jul; 450(1):697-703. PubMed ID: 24946211 [TBL] [Abstract][Full Text] [Related]
13. Increased Sphingosine Kinase 1 Expression Predicts Distant Metastasis and Poor Outcome in Patients With Colorectal Cancer. Bae GE; DO SI; Kim K; Park JH; Cho S; Kim HS Anticancer Res; 2019 Feb; 39(2):663-670. PubMed ID: 30711943 [TBL] [Abstract][Full Text] [Related]
14. SphK1 inhibitor II (SKI-II) inhibits acute myelogenous leukemia cell growth in vitro and in vivo. Yang L; Weng W; Sun ZX; Fu XJ; Ma J; Zhuang WF Biochem Biophys Res Commun; 2015 May; 460(4):903-8. PubMed ID: 25824043 [TBL] [Abstract][Full Text] [Related]
15. Preclinical study of cinobufagin as a promising anti-colorectal cancer agent. Lu XS; Qiao YB; Li Y; Yang B; Chen MB; Xing CG Oncotarget; 2017 Jan; 8(1):988-998. PubMed ID: 27894091 [TBL] [Abstract][Full Text] [Related]
16. Targeting the SphK1/S1P/PFKFB3 axis suppresses hepatocellular carcinoma progression by disrupting glycolytic energy supply that drives tumor angiogenesis. Liu XT; Huang Y; Liu D; Jiang YC; Zhao M; Chung LH; Han XD; Zhao Y; Chen J; Coleman P; Ting KK; Tran C; Su Y; Dennis CV; Bhatnagar A; Liu K; Don AS; Vadas MA; Gorrell MD; Zhang S; Murray M; Kavurma MM; McCaughan GW; Gamble JR; Qi Y J Transl Med; 2024 Jan; 22(1):43. PubMed ID: 38200582 [TBL] [Abstract][Full Text] [Related]
17. Sphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer models. Rosa R; Marciano R; Malapelle U; Formisano L; Nappi L; D'Amato C; D'Amato V; Damiano V; Marfè G; Del Vecchio S; Zannetti A; Greco A; De Stefano A; Carlomagno C; Veneziani BM; Troncone G; De Placido S; Bianco R Clin Cancer Res; 2013 Jan; 19(1):138-47. PubMed ID: 23166225 [TBL] [Abstract][Full Text] [Related]
18. The sphingosine kinase inhibitor SKI-V suppresses cervical cancer cell growth. Zhang Y; Cheng L; Shi X; Song Y; Chen XY; Chen MB; Yao J; Zhang ZQ; Cai S Int J Biol Sci; 2022; 18(7):2994-3005. PubMed ID: 35541904 [TBL] [Abstract][Full Text] [Related]
19. DNA-PKcs interference sensitizes colorectal cancer cells to a mTOR kinase inhibitor WAY-600. Wu L; Zhang J; Wu H; Han E Biochem Biophys Res Commun; 2015 Oct; 466(3):547-53. PubMed ID: 26381179 [TBL] [Abstract][Full Text] [Related]
20. mTOR inhibition sensitizes ONC201-induced anti-colorectal cancer cell activity. Jin ZZ; Wang W; Fang DL; Jin YJ Biochem Biophys Res Commun; 2016 Sep; 478(4):1515-20. PubMed ID: 27565731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]